Table 1

Patient details including immunophenotypic and cytogenetic analysis

PatientSex/AgeImmunophenotypeCRSurvival (weeks)Cytogenetic analysis
B, B lineage markers; CR, complete remission; ND, not done; SIg, surface immunoglobulin.
Cytogenetic abnormalities referred to in the text are highlighted in bold.
1F/66B+, SIg++Alive46,XX,t(8;14)(q24;q32)
2M/40B+, SIg+5 days46,XY,t(8;14)(q24;q32)
3M/79B+, Sig+146,XY,t(8;14)(q24;q32)
4F/46B+, Sig+1246,XX,t(8;14)(q24;q32)/46,idem,dup(1)(q?21q?32)
5F/58B+, SIg++Alive46,XX,t(8;14)(q24;q32)/46,idem,der(4)t(1;4)(q1?;q3?),der(22)t(7;22)(q11;p1?)
6M/55ND4 days46,XY,t(8;14)(q24;q32)/46,idem,dup(1)(q2?q32)
7F/36B+, SIg−1347,XX,t(8;14)(q24;q32),add(12)(p13)
8F/62B+, SIg−1546,XX,del(6)(q?),t(8;14)(q24;q32)/45,idem,−19
9F/83ND155−56,XX,+X,+X,+add(1)(p10),del(1)(q10),+7,t(8;14)(q24;q32),+11,del(16)(q?),+21,+21
10M/32B+, SIg+146,XY,dup(1)(q?25),t(3;22)(q29;q11),t(8;14)(q24;q32) /idem,add(14)(p11)
11F/62B+4 days47,XX,t(2;8)(p12;q24),+7,t(14;18)(q32;q21)
12M/41B+, SIg++4147,XY,add(1)(p36),add(3)(q2?3;?),+7,t(14;18)(q32;q22),t(15;22)(q26;q21),der(19)t(1;19)(q23;p13)
13F/72B+, SIg+147,XX,t(14;18)(q32;q21),+7
14M/42B+, SIg++4050,XY,t(14;18)(q32;q21),+der(X)t(X;1)(p11;q2?1),add(4)(p1),+7,add(7)(q22),ins(8;?)(q22−4?),add(11)(q23),+12,+20
15M/69B+, SIg+347,XY,+12,t(14;18)(q32;q22)
16M/76ND+1646,XY,dup(1)(q21;q32),add(14)(q32)/48,idem,+7,+12/47,idem,+12,der(13)t(7;13)(q12;q32)
17F/66B+, SIg+5 days45,XX,add(11)(q2?),der(13)t(13;22)(q32;q11?),add(14)(q32),der(19)t(12;19)(q13;p13.3),−22
18F/89B+2 days48,X,−X,−1,−3,del(6)(q1.?5),+add(7)(p?),+i(8)(p21),+9,+11,−13,−14,+15,−16,+add(18)(q22),+19,−20,−20,−21,+4
19M/46ND+5046,XY,del(9)(p21)/46,idem,+1,der(1;6)(q10;p10)/46,idem,+der(1)?i(1)(q10)
20M/20B++2046,XY
21M/53B++40Failed analysis
22M/53ND11ND
23F/39B+, SIg++51ND
24F/77B+, SIg+4 daysND